Fierce Pharma

OCTOBER 8, 2024

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, claiming its action to remove Eli Lilly’s Mounjaro and Zepbound from its drug shortage list is a “reckless and arbitrary decision—lacking any semblance of lawful process.” In declaring the end of the shortage, the FDA has halted the ability of compounding pharmacies to manufacture the in-demand products.

FDA 325

FDA Manufacturing 325

PharmaVoice

OCTOBER 8, 2024

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

145

145

Fierce Pharma

OCTOBER 8, 2024

Editor's Note: Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub in Tampa, Florida, in 2021—is setting out to bolster emergency services, pool donations and ease medical supply needs as Hurricane Milton touches down this week.

Medical 312

Medical 312

MedCity News

OCTOBER 8, 2024

When AI is directly integrated into the EHR it not only improves efficiency but also ensures that patient data remains secure within the same trusted system. The post EHRs Are Overloading Mental Health Clinicians — Can AI Save the Day? appeared first on MedCity News.

Patients 124

Patients Healthcare Healthcare 124

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

OCTOBER 8, 2024

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a new positive readout can return Keytruda to glory in head and neck cancer about two years after a prior failure.

306

306

MedCity News

OCTOBER 8, 2024

Astellas secured an exclusive option to license global rights to an AviadoBio gene therapy in development as a one-time treatment for a certain type of frontotemporal dementia. A Phase 1/2 test of the AviadoBio gene therapy is ongoing. The post Another Astellas Gene Therapy Deal, This Time $50M for Option on AviadoBio Dementia Program appeared first on MedCity News.

Biopharma 119

Biopharma Pharma 119

MedCity News

OCTOBER 8, 2024

The best solutions, in summary, are those that facilitate better outcomes while reducing costs — combining member health and satisfaction with healthcare savings. The post Point Solution Fatigue? Zooming Out to the Population Level Can Help appeared first on MedCity News.

Healthcare 116

Healthcare Healthcare Patients 116

Fierce Pharma

OCTOBER 8, 2024

With the U.S. | The Congressional Budget Office found that only one out of the seven policies it reviewed would create notable reductions in prices. Still, that approach could affect market dynamics outside the U.S.

Marketing 246

Marketing 246

pharmaphorum

OCTOBER 8, 2024

Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS in draft guidance

111

111

Fierce Pharma

OCTOBER 8, 2024

The neuroscience sector has seen a surge in investment over the past year, leading to breakthroughs and high-stakes dea | This week on "The Top Line," Fierce Pharma's Fraiser Kansteiner chats with industry leaders about the surge in neuroscience investment, breakthroughs and future targets in neuropharmaceuticals.

Pharma 147

Pharma Leads 147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

OCTOBER 8, 2024

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings in early 2025.The stock rocketed 362% after the announcement, taking Scholar Rock's market cap above $2.7 billion, as analysts started to talk about a blockbuster sales opportunity for the selective myostatin inhibitor.

Sales 111

Sales Marketing Patients 111

Integrity Solutions

OCTOBER 8, 2024

Building rapport in sales is essential for establishing trust and fostering long-term relationships with clients. While technology has made it easier than ever for buyers to access information, B2B buyers in particular are looking for insights and advice from a salesperson they can trust and who they believe has their best interests in mind to help them make good decisions.

Sales 106

Sales Prospecting Sales process Leads 106

pharmaphorum

OCTOBER 8, 2024

Biogen teams up with Talkiatry on telehealth programme for postpartum depression that could help drive sales of Zurzuvae

Sales 111

Sales 111

PharmaTimes

OCTOBER 8, 2024

Real-world studies show effectiveness of mogamulizumab in routine practice

100

100

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

OCTOBER 8, 2024

Astellas adds a gene therapy for frontotemporal dementia to its pipeline, via a $2.2bn+ option deal with UK biotech AviadoBio.

110

110

Pharmaceutical Technology

OCTOBER 8, 2024

The Phase III trials will evaluate survodutide in metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and cirrhosis.

98

98

pharmaphorum

OCTOBER 8, 2024

AstraZeneca and Owkin form alliance to develop an AI tool to pre-screen breast cancer patients for BRCA mutations from digital pathology slides.

Patients 107

Patients 107

European Pharmaceutical Review

OCTOBER 8, 2024

A study has indicated that single-step ion exchange treatment could enhance the properties of borosilicate glass vials using simple and easily scalable techniques. While borosilicate glass is the most common type of pharmaceutical container, it can be prone to certain issues that can endanger the safety and efficacy of the drugs inside the container, according to Abd-Elsatar et al.

Pharmaceutical 98

Pharmaceutical Safety Medical 98

Advertisement

PharmaTimes

OCTOBER 8, 2024

AviadoBio to receive up to £1.

93

93

pharmaphorum

OCTOBER 8, 2024

J&J's TAR-200 drug fails a phase 3 bladder cancer trial, but the company is still confident in the blockbuster potential of the programme

81

81

PharmaTech

OCTOBER 8, 2024

The winners of this year’s awards showcase achievements in pharma excellence.

Pharma 69

Pharma 69

Pharmaceutical Technology

OCTOBER 8, 2024

Bayer has entered a collaboration with MOMA Therapeutics in which the two companies will advance a small molecule oncology programme.

59

59

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTech

OCTOBER 8, 2024

Pharmaceutical Technology® Europe sat down with Álvaro Nocete Díaz, Pharma Division Manager at HTBA, about the benefits of flavonoids and their use in the pharmaceutical industry.

Pharmaceutical 69

Pharmaceutical Pharma Management 69

Pharmacy Times

OCTOBER 8, 2024

Survodutide is a glucagon/glucagon-like peptide-1 (GLP-1_ receptor dual agonist that activates the glucagon and GLP-1 receptors to better control metabolic function.

FDA 55

FDA 55

PharmaTech

OCTOBER 8, 2024

Andrew Lewis, PhD, Chief Scientific Officer, Quotient Sciences, discussed the CMC challenges with GLP-1 and oral peptides during CPHI Milan.

59

59

Pharma Marketing Network

OCTOBER 8, 2024

In an ever-evolving industry like healthcare, building a robust brand strategy is no longer optional but essential for pharma marketers. The dynamic landscape demands a comprehensive approach that not only elevates brand visibility but also fosters trust and credibility among consumers. As healthcare continues to integrate with technology, pharma marketers must navigate these changes adeptly to develop a winning healthcare brand strategy.

Healthcare 52

Healthcare Healthcare Marketing Pharma 52

Advertisement

Distribution

PharmaTech

OCTOBER 8, 2024

Webinar Date/Time: Thu, Nov 7, 2024 9:00 AM PST (12:00 PM EST)

52

52

ALULA

OCTOBER 8, 2024

Unlock Your Mental Potential This National Train Your Brain Day We've all heard "use it or lose it" when it comes to physical fitness, but did you know your brain follows the same principle? Just as you train your muscles, you can train your brain.

Training 52

Training 52

PharmaTech

OCTOBER 8, 2024

As a GMP manufacturing method, 3D printing offers benefits for modified release and personalized dosages.

Manufacturing 52

Manufacturing 52

PharmExec

OCTOBER 8, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52

Pharma 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales